Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Next Generation Sequencing: Research to Clinic
Conferences  \  Next Generation Sequencing: Research to Clinic  \  Agenda  \  Gitte Pedersen
RegisterLogin

Gitte Pedersen's Biography


Gitte Pedersen, Chief Executive Officer, Genomic Expression

Gitte L. Pedersen has more than 20 years of management experience in the biotech and pharma industry. She has held a number of executive positions at NovoZymes, where she successfully developed and launched new products worldwide. In 1997 she established an advisory firm, Proximity Ventures, and in that capacity, she has advised a number of biotech and government institutions resulting in numerous licensing and equity deals with companies such as GSK, JnJ, Merck, P&G, Wyeth, and Takeda. Her aggregated deal resume is more than $1 billion. Gitte Pedersen is the co-founder of Genomic Expression and has served as its CEO since 2009. Gitte has a masters in chemical engineering and a business degree.

Gitte Pedersen Image

Using RNA-seq Directly in the Clinic

Tuesday, 25 February 2014 at 17:15

Add to Calendar ▼2014-02-25 17:15:002014-02-25 18:15:00Europe/LondonUsing RNA-seq Directly in the ClinicNext Generation Sequencing: Research to Clinic in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

RNA is the biomarker of choice for a number of large commercial and reimbursed diagnostic products from e.g. Genomic Health and CardioDx. However using RNA-seq in the clinic remains challenging from a cost, time to answer and data handling perspective.  Genomic Expression’s “bait free” target filtering sample prep method solves most of the problems. The technology is platform-agnostic and can be applied with any sequencing platform reducing cost/sample a factor of 10 and providing an answer in less than 1 week and an out-put file of less of 30 MB. Genomic Expression is leveraging its technology and access to samples in a single payer system that implemented electronic medical records a decade ago, to provide a superior platform for development of Next Generation Diagnostics together with selected partners.

Add to Calendar ▼2014-02-24 00:00:002014-02-25 00:00:00Europe/LondonNext Generation Sequencing: Research to ClinicNext Generation Sequencing: Research to Clinic in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors